| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |